Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rienk Offringa

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|September 25, 2003
Magnitude and polarization of P53-specific T-helper immunity in connection to leukocyte infiltration of colorectal tumorsSjoerd H van der Burg, Anand G Menon, Anke Redeker, et al.
Science Translational Medicine|November 15, 2023
Transcriptome-based identification of tumor-reactive and bystander CD8<sup>+</sup> T cell receptor clonotypes in human pancreatic cancerZibo Meng, Aaron Rodriguez Ehrenfried, Chin Leng Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 7, 2007
Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigensSjoerd H van der Burg, Sytse J Piersma, Annemieke de Jong, et al.
Cancer Gene Therapy|July 2, 2003
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patientsAnand G Menon, Peter J K Kuppen, Sjoerd H van der Burg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccinationLucy J C Smyth, Mariëtte I E Van Poelgeest, Emma J Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localizationMaro H Sandel, Alisher R Dadabayev, Anand G Menon, et al.
International Journal of Cancer|August 19, 2005
Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasiaMariëtte I E van Poelgeest, Esther R Nijhuis, Kitty M C Kwappenberg, et al.
International Journal of Cancer|April 7, 2007
P53-specific T cell responses in patients with malignant and benign ovarian tumors: implications for p53 based immunotherapyAnnechien Lambeck, Ninke Leffers, Baukje-Nynke Hoogeboom, et al.
Oncoimmunology|January 27, 2017
Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinomaIsabel Poschke, Marta Faryna, Frank Bergmann, et al.
The Journal of Infectious Diseases|September 9, 2010
Evaluation of immunological cross-reactivity between clade A9 high-risk human papillomavirus types on the basis of E6-Specific CD4+ memory T cell responsesMuriel van den Hende, Anke Redeker, Kitty M C Kwappenberg, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|September 25, 2003
Magnitude and polarization of P53-specific T-helper immunity in connection to leukocyte infiltration of colorectal tumorsSjoerd H van der Burg, Anand G Menon, Anke Redeker, et al.
Science Translational Medicine|November 15, 2023
Transcriptome-based identification of tumor-reactive and bystander CD8<sup>+</sup> T cell receptor clonotypes in human pancreatic cancerZibo Meng, Aaron Rodriguez Ehrenfried, Chin Leng Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 7, 2007
Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigensSjoerd H van der Burg, Sytse J Piersma, Annemieke de Jong, et al.
Cancer Gene Therapy|July 2, 2003
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patientsAnand G Menon, Peter J K Kuppen, Sjoerd H van der Burg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccinationLucy J C Smyth, Mariëtte I E Van Poelgeest, Emma J Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localizationMaro H Sandel, Alisher R Dadabayev, Anand G Menon, et al.
International Journal of Cancer|August 19, 2005
Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasiaMariëtte I E van Poelgeest, Esther R Nijhuis, Kitty M C Kwappenberg, et al.
International Journal of Cancer|April 7, 2007
P53-specific T cell responses in patients with malignant and benign ovarian tumors: implications for p53 based immunotherapyAnnechien Lambeck, Ninke Leffers, Baukje-Nynke Hoogeboom, et al.
Oncoimmunology|January 27, 2017
Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinomaIsabel Poschke, Marta Faryna, Frank Bergmann, et al.
The Journal of Infectious Diseases|September 9, 2010
Evaluation of immunological cross-reactivity between clade A9 high-risk human papillomavirus types on the basis of E6-Specific CD4+ memory T cell responsesMuriel van den Hende, Anke Redeker, Kitty M C Kwappenberg, et al.
Pageof 12